You do not have to be young to get a vaccine against human papillomavirus (HPV).
The US Food and Drug Administration (FDA) expanded the age-old guide for vaccination.
People who are dating between 27 and 45 who have not been vaccinated before may now be Gardasil 9.
HPV vaccine vaccines in the United States continue to grow, but the country remains in control of the spread of sexually transmitted diseases.
About half of teenagers know HPV vaccine. It promises for the future, but most adult women and men are still at risk.
FDA's guideline change is partly driven by positive influenza vaccine influenza vaccine, especially cervical cancer.
While other experts hope, this extra age group will help remove HPV in the United States, others are not sure that this change can make any difference.
What experts say is that
Healthline talks with Cynthia Leifer, PhD, associate professor of microbiology and immunology departments at Cornell University in New York.
She supports new FDA standards, but also recognizes adults who are incapacitated by vaccination.
He said that "many adults have forgotten, or do not know, that they still need vaccinations."
To get this effect, Leifer said: "Primary care doctors should inform their patients of this new option."
Dr. Ian Frazer, an immunologist and professor who is best known for inventing basic technology behind HPV vaccines, is not sure that a new age guide leads to higher rates of vaccination.
Although he claimed he was not an American policy expert, he said his American colleagues said success had been in line with the need for 'vaccination companies' insurance coverage.'
Comparison of coverage coverage and immunization rates throughout the world testifies to the argument. High-income countries with higher insurance coverage see more vaccine rates.
Currently, the vaccine is covered by several insurance companies in some US states and is in the patient's position to find this information. This makes it difficult to access.
In cases where insurance coverage is available, it is not immediately.
Patients need to pay the costs and wait for payment, which creates a new financial risk that will reduce the chance of vaccination.
"There is always a lot of insurance coverage, so anyone who wants the vaccine and over 25 years of age need to pay for it," Dr. Nanette Santoro, professor and chair of obstetrics and gynecology at the University of Colorado. School of Medicine, speaks to Healthline. "However, it's a good idea to check your insurance."
He said that the costs are $ 300, but "it's a good health care investment."
What needs to be known to every adult
There are over 100 subtypes in HPV and the virus causes 99 percent of cases of cervical cancer.
If you had not previously been vaccinated, the possibilities were then exposed to the virus.
So what is used to be vaccinated afterwards?
"Although they may have been exposed to HPV, [adults] benefit from the unpredictability of all carcinogenic subtypes," said Santoro.
This is not strictly about HPV. It also considers reducing your risk factors for certain types of cancer.
"The benefit is an immunity to the wider range of HPV classes, and long-term benefits can be low risk for oral and anal cancer, with the low risk of cervical cancer," said Santoro.
So even if you are exposed to HPV - and even if you have cervical cancer - it is important to be immunized.
Santoro said some of his colleagues on oncology admitted that they would not be able to get vaccinated later.
"There are still protocols where women with cervical cancer get the vaccine to cope with the illness," he said.
it will come to
Experts say that all adults aged 27 and 45 who have not been vaccinated before the HPV should also do so.
This age group can now be for the HPV vaccine due to the recent change in FDA standards.
However, experts say that insurance companies should include vaccine costs if the United States HPV vaccine coverage adds.
Michelle Pugle wrote on October 16, 2018
